BIOVF OTC
Swedish Orphan Biovitrum AB (publ)
1W: -10.9%
1M: -10.9%
3M: -10.6%
YTD: +21.7%
1Y: +42.8%
3Y: +113.7%
$42.90
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$67.3B
-10.8% ▼
5Y CAGR: +6.9%
Total Liabilities
$29.6B
-15.7% ▼
5Y CAGR: +1.1%
Shareholders Equity
$37.6B
-6.6% ▼
5Y CAGR: +13.2%
Cash & Investments
$1.0B
-8.9% ▼
5Y CAGR: +20.8%
Total Debt
$11.7B
-29.9% ▼
5Y CAGR: -4.3%
Net Debt
$10.7B
-31.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.0B | $1.4B | $904M | $1.1B | $1.0B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $1.0B | $1.4B | $904M | $1.1B | $1.0B |
| Net Receivables | $4.3B | $6.1B | $6.9B | $7.9B | $8.3B |
| Inventory | $3.4B | $3.3B | $3.9B | $4.2B | $5.1B |
| Other Current Assets | $4.1B | $6.1B | $208M | $1M | -$1K |
| Total Current Assets | $8.8B | $11.2B | $12.7B | $13.2B | $14.5B |
| Property, Plant & Equip. | $493M | $274M | $251M | $1.6B | $1.6B |
| Goodwill & Intangibles | $38.4B | $40.0B | $59.0B | $59.0B | $49.0B |
| Long-Term Investments | $199M | $121M | $37M | $36M | $1.2B |
| Other Non-Current Assets | $1M | $0 | $2.1B | $398M | $211M |
| Total Non-Current Assets | $39.9B | $41.3B | $61.4B | $62.3B | $52.8B |
| Total Assets | $48.7B | $52.5B | $74.0B | $75.4B | $67.3B |
| — Liabilities — | |||||
| Accounts Payable | $558M | $1.3B | $1.0B | $944M | $1.2B |
| Short-Term Debt | $1.8B | $5.8B | $8.8B | $3.9B | $6.0B |
| Deferred Revenue | $5.3B | $3.1B | $0 | $0 | $0 |
| Other Current Liabilities | $6.0B | $7.3B | $8.8B | $7.6B | $8.8B |
| Total Current Liabilities | $8.8B | $14.9B | $19.1B | $12.6B | $16.0B |
| Long-Term Debt | $8.8B | $3.0B | $11.4B | $12.4B | $5.4B |
| Other Non-Current Liab. | $7.4B | $7.9B | $9.5B | $3.2B | $3.6B |
| Total Non-Current Liabilities | $16.7B | $11.1B | $21.1B | $22.5B | $13.6B |
| Total Liabilities | $25.5B | $26.0B | $40.2B | $35.1B | $29.6B |
| — Equity — | |||||
| Common Stock | $169M | $170M | $194M | $195M | $196M |
| Retained Earnings | $13.2B | $15.8B | $18.1B | $21.9B | $22.3B |
| Accumulated OCI | -$66M | $351M | $0 | $0 | $0 |
| Total Stockholders Equity | $23.2B | $26.5B | $33.9B | $40.3B | $37.6B |
| Total Liabilities & Equity | $48.7B | $52.5B | $74.0B | $75.4B | $67.3B |
| — Key Metrics — | |||||
| Total Debt | $10.9B | $9.1B | $20.5B | $16.7B | $11.7B |
| Net Debt | $9.9B | $7.7B | $19.6B | $15.6B | $10.7B |
| Total Investments | $190M | $112M | $37M | $36M | $1.2B |